Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Growth stocks
ESG stocks
Trend-Following Stocks
Momentum stocks
Quality stocks
Undervalued stocks
Investment Themes
Boats
Europe's family businesses
Place your bets
The future of mobility
The SPAC
Strategic Metals
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
Strategic Metals
Cybersecurity
Ageing Population
Let's all cycle!
Hydrogen
Artificial Intelligence
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
Switzerland
Swiss Exchange
Addex Therapeutics Ltd
News
Summary
ADXN
CH0029850754
ADDEX THERAPEUTICS LTD
(ADXN)
Add to my list
Report
Delayed Swiss Exchange -
07:03 2022-08-16 am EDT
0.2310
CHF
-3.75%
08/15
ADDEX THERAPEUTICS
: and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance Use Disorders - Form 6-K
PU
08/15
Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding
MT
08/15
Addex, Indivior to Include Chronic Cough Indication in Research Collaboration
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about ADDEX THERAPEUTICS LTD
08/15
ADDEX THERAPEUTICS
: and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..
PU
08/15
Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding
MT
08/15
Addex, Indivior to Include Chronic Cough Indication in Research Collaboration
MT
08/15
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
GL
08/15
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
DJ
08/15
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
CI
08/12
Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
GL
08/12
Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
AQ
07/27
Addex Therapeutics Raises $4 Million In Americal Depositary Receipts Offering
MT
07/26
ADDEX THERAPEUTICS
: Completes $4.2 Million Equity Financing - Form 6-K
PU
07/26
Addex Completes $4.2 Million Equity Financing
GL
07/26
Addex Completes $4.2 Million Equity Financing
DJ
07/26
Addex Therapeutics Ltd announced that it has received $2.9575 million in funding from A..
CI
07/22
Addex Therapeutics Signs $4.2 Million Equity Financing Deal With Armistice Master Fund
MT
07/22
ADDEX THERAPEUTICS
: Raises $4.2 million in Equity Financing - Form 6-K
PU
More most relevant news
All news about ADDEX THERAPEUTICS LTD
08/15
ADDEX THERAPEUTICS
: and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..
PU
08/15
Addex Therapeutics, Indivior PLC Extend Collaboration Deal, Adds Research Funding
MT
08/15
Addex, Indivior to Include Chronic Cough Indication in Research Collaboration
MT
08/15
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
GL
08/15
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
DJ
08/15
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
CI
08/12
Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
GL
08/12
Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
AQ
07/27
Addex Therapeutics Raises $4 Million In Americal Depositary Receipts Offering
MT
07/26
ADDEX THERAPEUTICS
: Completes $4.2 Million Equity Financing - Form 6-K
PU
More news
News in other languages on ADDEX THERAPEUTICS LTD
08/15
Addex Therapeutics et Indivior PLC prolongent leur accord de collaboration et ajoutent ..
08/15
Addex et Indivior vont inclure l'indication de la toux chronique dans leur collaboratio..
08/15
Addex erweitert Zusammenarbeit mit Indivior und sichert sich zusätzliche Mittel
08/15
Addex étend sa collaboration avec Indivior
08/15
Addex et Indivior étendent leur collaboration en matière de recherche sur les modulateu..
07/27
Addex Therapeutics lève 4 millions de dollars dans le cadre d'une offre de certificats ..
07/26
Addex a finalisé une augmentation de capital
07/26
Addex schliesst Aktienkapitalerhöhung ab
07/22
Aktien Schweiz von schwachen Daten belastet
07/22
Addex Therapeutics signe un accord de financement par actions de 4,2 millions de dollar..
More news
Analyst Recommendations on ADDEX THERAPEUTICS LTD
06/23
HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy
MT
05/31
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Ratin..
MT
02/11
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy R..
MT
2021
ADDEX THERAPEUTICS
: HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Pri..
MT
More recommendations
Press releases
08/15
ADDEX THERAPEUTICS
: and Indivior Extend GABAB Positive Allosteric Modulator Research Coll..
PU
08/15
Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration fo..
GL
08/12
Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
GL
08/12
Addex Therapeutics to Report Half-Year 2022 Financial Results and Host Conference Call ..
AQ
07/26
ADDEX THERAPEUTICS
: Completes $4.2 Million Equity Financing - Form 6-K
PU
More press releases
Powered by Scoopnest.com
Upcoming event on ADDEX THERAPEUTICS LTD
08/18/22
Interim 2022 Earnings Call
Company calendar
Upcoming sector events
10/26/22
IQVIA HOLDINGS INC.
: Q3 2022 Earnings Release (Projected)
10/27/22
ALNYLAM PHARMACEUTICALS, INC.
: Q3 2022 Earnings Release (Projected)
10/27/22
SEAGEN INC.
: Q3 2022 Earnings Release (Projected)
11/03/22
MODERNA, INC.
: Q3 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research
Slave